Cheng-Chung Wu

Title: Cheng-Chung Wu: Innovator in Cancer Research

Introduction

Cheng-Chung Wu is a notable inventor based in Sanchong, Taiwan. He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 2 patents, his work focuses on enhancing the understanding and treatment of cancer.

Latest Patents

One of Cheng-Chung Wu's latest patents is related to the Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequences. This invention provides a transcription unit isolated from the upstream nucleic acid sequence of the CRMP-1 gene, which is recognized as an invasion-suppressor gene. The transcription unit contains a nucleic acid regulatory sequence that demonstrates promoter and/or regulatory activities, enhancing the expression of CRMP-1 and/or a reporter protein. Additionally, the invention includes a DNA construct containing this transcription unit, which can be transfected into a host cell. The methods provided by this invention aim to enhance the expression of CRMP-1 and/or the reporter protein, with the over-expression of CRMP-1 in cancer cells potentially inhibiting their metastasis.

Career Highlights

Cheng-Chung Wu is currently associated with Advpharma, Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, particularly for its implications in cancer treatment.

Collaborations

Cheng-Chung Wu has collaborated with notable colleagues, including Pan-Chyr Yang and Tse-Ming Hong. Their combined expertise contributes to the advancement of research in their respective fields.

Conclusion

Cheng-Chung Wu's contributions to cancer research through his innovative patents highlight his role as a significant inventor in the scientific community. His work continues to pave the way for advancements in cancer treatment and understanding.